A therapeutic trial with a combination of trimethoprim-sulphamethoxazole in rheumatoid arthritis.
D000328:Adult; D000890:Anti-Infective Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001799:Blood Sedimentation; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D005260:Female; D005493:Folic Acid Antagonists / Q000008:administration & dosage* / Q000627:therapeutic use; D006452:Hemoglobinometry; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D009119:Muscle Contraction; D011743:Pyrimidines / Q000008:administration & dosage* / Q000627:therapeutic use; D013420:Sulfamethoxazole / Q000008:administration & dosage* / Q000627:therapeutic use; D014295:Trimethoprim / Q000627:therapeutic use
D000890:Anti-Infective Agents; D004338:Drug Combinations; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D014295:Trimethoprim; D013420:Sulfamethoxazole